Back
Traws Pharma, Inc. 10K Form
Sell
2
TRAW
Traws Pharma, Inc.
Last Price:
$1.24
Seasonality Move:
-2.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRAW News And Ratings
See the #1 stock for the next 7 days that we like better than TRAW
TRAW Financial Statistics
Sales & Book Value
| Annual Sales: | $226K |
|---|---|
| Cash Flow: | $-4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.64 |
| Price / Book: | 2.46 |
Profitability
| EPS (TTM): | 24.08020 |
|---|---|
| Net Income (TTM): | $93.4M |
| Gross Margin: | $214K |
| Return on Equity: | -124.39% |
| Return on Assets: | 576.05% |
Traws Pharma, Inc. Earnings Forecast
Key Traws Pharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for TRAW is 94.69%.
-
The Selling, General & Administrative Expenses for TRAW have been equal to 5,437.61% of Gross Profit Margin.
-
The Research & Development expenses have been 5,679.20% of Revenue.
-
The Net Earning history of TRAW is -24,192.04% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 10 years.
Traws Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TRAW |
| Website: | trawspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.22 |
| Quick Ratio: | 1.07 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRAW Technical Analysis vs Fundamental Analysis
Sell
2
Traws Pharma, Inc. (TRAW)
is a Sell
Is Traws Pharma, Inc. a Buy or a Sell?
-
Traws Pharma, Inc. stock is rated a SellThe current Traws Pharma, Inc. [TRAW] share price is $1.40. The Score for TRAW is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.